100
Participants
Start Date
August 31, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
December 23, 2016
obinutuzumab
1000 mg intravenously on Day 1 of each 21-day cycle, 8 cycles; during Cycle 1 administration also on Days 8 and 15.
cyclophosphamide
750 mg/m\^2 intravenous (IV), Day 1 of each 21-day cycle, 6 cycles.
doxorubicin
50 mg/m\^2 IV, Day 1 of each 21-cycle, 6 cycles.
prednisone
100 mg/day, Days 1 through 5 of each 21-day cycle, 6 cycles.
vincristine
1.4 mg/m\^2 IV, Day 1 of each 21-day cycle, 6 cycles.
Memorial Sloan Kettering Cancer Center, New York
MSKCC at Sleepy Hollow, Sleepy Hollow
MSKCC at Mercy Med Ctr, Rockville Centre
Memorial Sloan-Kettering; Cancer Center, Commack
Blue Ridge Cancer Care - Roanoke, Roanoke
Emerywood Hematology and Onc, High Point
Medical University of SC (MUSC), Charleston
Northwest Georgia Oncology Centers PC - Marietta, Marietta
Florida Cancer Specialists; Saint Petersburg, St. Petersburg
SCRI-Tennessee Oncology, Nashville
Jewish Cancer Care, Louisville
McFarland Clinic, Ames
Aurora Bay Care Medical Center, Green Bay
MT Cancer Inst Fndtn; MT Can Spec, Missoula
Northwestern University; Robert H. Lurie Comp Can Ctr, Chicago
USO - Tyler Cancer Ctr, Tyler
Onc & Hem Assoc; USO Cent Pharm, Fort Worth
MD Anderson Cancer Center Department of Lymphoma & Myeloma, Houston
Methodist Hospital Research Institute, Houston
Cancer Therapy & Research Center, San Antonio
University of Colorado Cancer Center Department of Hematology, Aurora
Rocky Mountain Cancer Ctr - Denver (Williams), Denver
Kootenai Medical Center, Coeur d'Alene
San Juan Oncology Associates, Farmington
Comprehensive Cancer Centers of Nevada, Las Vegas
cCare, Encinitas
Willamette Valley Cancer Insitute and Research Center, Springfield
Northwest Cancer Specialists - Vancouver, Vancouver
Yakima Valley Memorial Hospital/North Star Lodge, Yakima
Medical Oncology Associates, Spokane
University of Alabama at Birmingham, Birmingham
Norwalk Hospital, Norwalk
Florida Cancer Specialists; Department of Oncology, Fort Myers
Onc Hem Assoc of Central IL, Peoria
University of Massachusetts Medical School, Worcester
University of Michigan, Ann Arbor
MSKCC at Basking Ridge, Basking Ridge
Hackensack University Medical Center, Hackensack
Lead Sponsor
Genentech, Inc.
INDUSTRY